Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III Study of Intravenous Ibandronic Acid (R484iv) in Primary Osteoporosis
jRCT2080220364Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ibandronic acid in involutional osteoporosis, sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
ibandronic acid
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on jRCT2080220364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220364.